Javascript must be enabled to continue!
What influences communication about retention in randomised trials: a multi-trial, theory-based analysis exploring trial staff perspectives
View through CrossRef
Abstract
Background
Retention (participants completing a trial) is a persistent, and often under-studied, challenge within clinical trials. Research on retention has focussed on understanding the actions of participants who decide to remain or withdraw from trial participation and developing interventions to target improvements. To better understand how trial staff may influence participants to remain or withdraw from trials, it is important to explore the experiences of staff that recruit and retain said participants and how the process of recruitment impacts retention.
Methods
Two qualitative interview studies informed by the Theoretical Domains Framework (TDF) were conducted with staff involved in various stages of clinical trials. The first set of interviews were focussed on staff perceptions about why participants failed to be retained and what helped to keep others engaged in trials, but also explored more generally what strategies or factors contributed to retention in trials. The second set of interviews were focussed on staff perceptions specifically about the recruitment and informed consent process and how that may influence trial retention. All interviews were analysed using the TDF and assigned to relevant behavioural domains according to perceived barriers/facilitators of the target behaviour. Belief statements were generated, summarising the narrative content of related responses within these behavioural domains. These belief statements were further analysed for themes that captured higher order relationships between separate beliefs within and between behavioural domains.
Results
Twenty-five participants (9 retention staff and 16 recruitment staff) were interviewed. Themes describing the barriers/facilitators to retention broadly, and to communication of retention information at consent, were generated. Four themes on retention broadly and six themes on communication of retention information at consent were identified. Overall, beliefs within all fourteen TDF domains populated these themes.
Conclusions
This study explored staff perspectives on retention and how they interpret their behaviour as contributing to retention success. Perspectives varied considerably but several key themes regarding communication were seen consistently. Specific barriers and facilitators within these findings will serve to guide the design of a behavioural intervention aimed at addressing issues within retention. Findings contribute to a notable gap in the literature on staff behaviour in trials and on retention generally.
Springer Science and Business Media LLC
Title: What influences communication about retention in randomised trials: a multi-trial, theory-based analysis exploring trial staff perspectives
Description:
Abstract
Background
Retention (participants completing a trial) is a persistent, and often under-studied, challenge within clinical trials.
Research on retention has focussed on understanding the actions of participants who decide to remain or withdraw from trial participation and developing interventions to target improvements.
To better understand how trial staff may influence participants to remain or withdraw from trials, it is important to explore the experiences of staff that recruit and retain said participants and how the process of recruitment impacts retention.
Methods
Two qualitative interview studies informed by the Theoretical Domains Framework (TDF) were conducted with staff involved in various stages of clinical trials.
The first set of interviews were focussed on staff perceptions about why participants failed to be retained and what helped to keep others engaged in trials, but also explored more generally what strategies or factors contributed to retention in trials.
The second set of interviews were focussed on staff perceptions specifically about the recruitment and informed consent process and how that may influence trial retention.
All interviews were analysed using the TDF and assigned to relevant behavioural domains according to perceived barriers/facilitators of the target behaviour.
Belief statements were generated, summarising the narrative content of related responses within these behavioural domains.
These belief statements were further analysed for themes that captured higher order relationships between separate beliefs within and between behavioural domains.
Results
Twenty-five participants (9 retention staff and 16 recruitment staff) were interviewed.
Themes describing the barriers/facilitators to retention broadly, and to communication of retention information at consent, were generated.
Four themes on retention broadly and six themes on communication of retention information at consent were identified.
Overall, beliefs within all fourteen TDF domains populated these themes.
Conclusions
This study explored staff perspectives on retention and how they interpret their behaviour as contributing to retention success.
Perspectives varied considerably but several key themes regarding communication were seen consistently.
Specific barriers and facilitators within these findings will serve to guide the design of a behavioural intervention aimed at addressing issues within retention.
Findings contribute to a notable gap in the literature on staff behaviour in trials and on retention generally.
Related Results
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Radical prostatectomy is the most commonly performed treatment option for localised prostate cancer. In the last decades the surgical technique has been improved and modified in or...
Benchmarking observational studies against randomised trials
Benchmarking observational studies against randomised trials
<p dir="ltr">Randomised trials are regarded as the gold standard in evaluating the effectiveness and safety of medical interventions, but they are not always feasible due to ...
Benchmarking observational studies against randomised trials
Benchmarking observational studies against randomised trials
<p dir="ltr">Randomised trials are regarded as the gold standard in evaluating the effectiveness and safety of medical interventions, but they are not always feasible due to ...
Warszawska konspiracja więzienna 1939-1944 (udział polskiego personelu)
Warszawska konspiracja więzienna 1939-1944 (udział polskiego personelu)
Taken over by the Nazi in September 1939, Polish prisons became not only the gallows of many thousands of Poles but also the site of heroic struggle against the invaders ‒ a strugg...
Developing strategies to address disparities in retention communication during the consent discussion: development of a behavioural intervention
Developing strategies to address disparities in retention communication during the consent discussion: development of a behavioural intervention
Abstract
Background
Clinical trials are essential to evidence-based medicine. Their success relies on recruitment and retention of participants: pro...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Staff Wellbeing and Networks Support (SWANS) Study
Staff Wellbeing and Networks Support (SWANS) Study
BACKGROUND
Anecdotal evidence from Lincolnshire National Health Service (NHS) Provider Trusts alluded to widely publicised reports of increased levels of stress and anxiety among ...
Global Distribution and Characteristics of Research Facilities Participating in Phase III Oncology Trials
Global Distribution and Characteristics of Research Facilities Participating in Phase III Oncology Trials
ABSTRACT
Background
Research infra-structure is essential for conducting phase III cancer clinical trials as its lack precludes...

